SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-006973
Filing Date
2023-05-26
Accepted
2023-05-26 16:25:58
Documents
18
Period of Report
2023-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_052423.htm   iXBRL 8-K 77571
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS ex3-1.htm EX-3.1 75005
3 LETTER DATED MAY 24, 2023 ex10-1.htm EX-10.1 11691
4 OFFER LETTER DATED MAY 24, 2023 ex10-2.htm EX-10.2 33586
5 DMK 2016 STOCK PLAN ex10-3.htm EX-10.3 107948
6 PRESS RELEASE ex99-1.htm EX-99.1 15761
10 GRAPHIC admp-005.jpg GRAPHIC 3199
  Complete submission text file 0001387131-23-006973.txt   582514

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE admp-20230524.xsd EX-101.SCH 2998
8 XBRL LABEL FILE admp-20230524_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE admp-20230524_pre.xml EX-101.PRE 22385
12 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_052423_htm.xml XML 3702
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 23969362
SIC: 2834 Pharmaceutical Preparations